ATEC Spine - ATEC Short-Term Debt to Capital

ATEC (Alphatec Holdings, Inc.) - company brandmark

Alphatec Holdings, Inc. (ATEC) specializes in developing systems for spinal surgeries. The business faces intense pressure from market leaders and titanium logistics disruptions, which are impacting profitability. Energetic management is striving for a rapid update of the product line, while an ambitious strategy to capture the niche is supported by shareholders. The market dynamics reflected in the price action confirm these trends, with the metric standing at 0.00.

ATEC - Alphatec Holdings Short-Term Debt to Equity Ratio over the range 07/04/2022 - 10/31/2026
Brand item of Alphatec

This ratio measures the proportion of liabilities maturing within one year relative to equity, determining the issuer's ability to service operational loans without risking insolvency. Analyzing this short-term debt-to-equity chart, an investor can see how Alphatec Holdings, Inc. (ATEC) balances its financial leverage against an aggressive capture of the spine surgery niche through the implementation of innovative patents.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|insulet.com (PODD) - Current Liabilities to Capital|Zimmer Biomet Holdings - Short-Term Debt to Capital|The Cooper Companies, Inc. (COO) - Short-Term Debt to Equity Ratio|ALGN: Short-Term Debt to Capital|GMED - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital artivion.com|Short-Term Debt to Equity Enovis (ENOV)|Short-Term Debt to Equity IART (Integra LifeSciences Corp)|Short-Term Debt to Capital ESTA (Motiva)|Short-Term Debt to Capital Coefficient iLet Bionic Pancreas (BBNX)|IRMD: Short-Term Debt to Equity Ratio|Current Liabilities to Equity EMBC|TNDM: Short-Term Debt to Capital|Current Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Short-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Short-Term Debt to Equity Ratio|Carlsmed Corp - Short-Term Debt to Capital|Current Liabilities to Capital RxSight Ophthalmic|CLPT: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Short-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital OBIO|Short-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Short-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Short-Term Debt to Equity|XTNT: Short-Term Debt to Equity|NMTC (NeuroOne Corp) - Short-Term Debt to Equity Ratio|Modular Medical, Inc. - Ratio of Short-Term Indebtedness to Capital|MYO (Myomo, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital envoymedical.com COCH|Short-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Short-Term Indebtedness to Equity|Sintx Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Current Liabilities to Equity BBLG (Bone Biologics Corp.)|Short-Term Debt to Equity Axonics Modulation Technologies|Short-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO